Advertisement

Archives of Sexual Behavior

, Volume 31, Issue 2, pp 211–215 | Cite as

Clinical Characteristics and Treatment Response to SSRI in a Female Pedophile

  • Eva W. C. Chow
  • Alberto L. Choy
Article

Abstract

Although much investigation has been done with male sex offenders, there have been few studies on female sex offenders. Female sex offenders have been reported as having a high incidence of psychiatric disorders, but female paraphilics were rarely described. The literature on the treatment of female sex offenders is also limited and treatment with a selective serotonin reuptake inhibitor (SSRI) has not been reported. This paper presents the case of a woman with DSM-IV pedophilia. Her clinical characteristics, her offense history, and her positive response to treatment with sertraline (a SSRI) are described. This case adds to the limited literature on female pedophiles and suggests that SSRIs may be an effective treatment for paraphilic disorders in female sex offenders.

female pedophile female sex offenders sertraline selective serotonin reuptake inhibitor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Abouesh, A. I., & Clayton, A. H. (1999). Compulsive voyeurism and exhibitionism: A clinical response to paroxetine. Archives of Sexual Behavior, 28, 23-30.Google Scholar
  2. Badgely, R. (1984). Sexual offences against children. Ottawa: Badgely Commission.Google Scholar
  3. Bradford, J. (1996). The role of serotonin in the future of forensic psychiatry. Bulletin of the American Academy of Psychiatry and the Law, 24, 57-72.Google Scholar
  4. Bradford, J. M., & Pawlak, A. E. (1993). Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Archives of Sexual Behavior, 22, 383-402.Google Scholar
  5. Buss, A. H., & Plomin, R. (1975). A temperament theory of personality development. New York: Wiley.Google Scholar
  6. Clayton, A. (1993). Fetishism and Clomipramine. American Journal of Psychiatry, 150, 673-674.Google Scholar
  7. Coccaro, E. F., & Kavoussi, R. J. (1997). Fluoxetine and impulsive behavior in personality-disordered subjects. Archives of General Psychiatry, 54, 1081-1088.Google Scholar
  8. Cooper, A. J., Ismail, A. A., Phanjoo, A. L., & Love, D. L. (1972). Antiandrogen (cyproterone) therapy in deviant hypersexuality. British Journal of Psychiatry, 120, 59-63.Google Scholar
  9. Cooper, A. J., Swaminath, S., Baxter, D., & Poulin, C. (1990). A female sex offender with multiple paraphilias: A psychologic, physiologic (laboratory sexual arousal) and endocrine case study. Canadian Journal of Psychiatry, 35, 334-337.Google Scholar
  10. Davanzo, P. A., Belin, T. R., Widawski, M. H., & King, B. H. (1998). Paroxetine treatment of aggression and self-injury in persons with mental retardation. American Journal of Mental Retardation, 102, 427-437.Google Scholar
  11. Derogatis, L. R. (1994). Symptom Checklist-90-R.Administration, Scoring, and Procedures Manual (3rd ed.). Minneapolis: National Computer Systems, Inc.Google Scholar
  12. Dickey, R. L. (1989). Pharmacological treatment of sexually anomalous behavior. Drug Protocol, 4, 7-10.Google Scholar
  13. Durst, R., Katz, G., & Knobler, H. Y. (1997). Buspirone augmentation of fluvoxamine in the treatment of kleptomania. Journal of Nervous and Mental Disease, 185, 586-588.Google Scholar
  14. Fedoroff, J. P. (1993). Serotonergic drug treatment of deviant sexual interests. Annals of Sex Research, 6, 105-121.Google Scholar
  15. Fedoroff, J. P. (1995). Antiandrogen vs. serotonergic medications in the treatment of sex offenders: A preliminary compliance study. Canadian Journal of Human Sexuality, 4, 111-122.Google Scholar
  16. Fedoroff, J. P., & Fedoroff, I. C. (1992). Buspirone and paraphilic sexual behaviour. Journal of Offender Rehabilitation, 18, 89-108.Google Scholar
  17. Gijs, L., & Gooren, L. J. (1996). Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update. Journal of Sex Research, 33, 273-290.Google Scholar
  18. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C. M., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. Archives of General Psychiatry, 46, 1006-1011.Google Scholar
  19. Green, A. H., & Kaplan, M. S. (1994). Psychiatric impairment and childhood victimization experiences in female child molesters. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 954-961.Google Scholar
  20. Greenberg, D. M., & Bradford, J. M. (1997). Treatment of the paraphilia disorders: A review of the role of the selective serotonin reuptake inhibitors. Sexual Abuse: A Journal of Research and Treatment, 9, 349-360.Google Scholar
  21. Greenberg, D. M., Bradford, J. M., Curry, S., & O'Rourke, A. B. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Bulletin of the American Academy of Psychiatry and the Law, 24, 525-532.Google Scholar
  22. Grier, P. E., Clark, M., & Stoner, S. B. (1993). Comparative study of personality traits of female sex offenders. Psychological Reports, 73, 1378.Google Scholar
  23. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.Google Scholar
  24. Hamilton, M. (1960). Arating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.Google Scholar
  25. Hollander, E., DeCaria, C. M., Mari, E., Wong, C. M., Mosovich, S. A., Grossman, R., et al. (1998). Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry, 155, 1781-1783.Google Scholar
  26. Kafka, M. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia related disorders: An open trial. Annuals of Clinical Psychiatry, 6, 189-195.Google Scholar
  27. Kafka, M. P., & Prentky, R. A. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 53, 351-358.Google Scholar
  28. Kavoussi, R. J., & Coccaro, E. F. (1994). An open trial of sertraline in personality disordered patients with impulsive aggression. Journal of Clinical Psychiatry, 55, 137-141.Google Scholar
  29. Knopp, F. H., & Lackey, L.B. (1987). Female sexual abusers: A summary of data from 44 treatment providers. Orwell, VT: The Safer Society Program of the New York State Council of Churches.Google Scholar
  30. Kravitz, H. M., Haywood, T. W., Kelly, J., Wahlstrom, C., Liles, S., & Cavanaugh, J. L. (1995). Medroxyprogesterone treatment for paraphilia. Bulletin of the American Academy of Psychiatry and the Law, 23, 19-33.Google Scholar
  31. Marvasti, J. (1986). Incestuous mothers.American Journal of Forensic Psychiatry, 7, 63-69.Google Scholar
  32. Mellor, C. S., Farid, N. R., & Craig, D. F. (1988). Female hypersexuality treated with cyproterone acetate. American Journal of Psychiatry, 145, 1037.Google Scholar
  33. O'Connor, A. (1987). Female sex offenders. British Journal of Psychiatry, 150, 615-620.Google Scholar
  34. Perilstein, R. D., Lipper, S., & Friedman, L. J. (1991). Three cases of pedophila responsive to fluoxetine treatment. Journal of Clinical Psychiatry, 52, 169-170.Google Scholar
  35. Travin, S., Cullen, K., & Protter, B. (1990). Female sex offenders: Severe victims and victimizers. Journal of Forensic Sciences, 35, 140-150.Google Scholar
  36. Wolfe, F. (1985). Twelve female sexual offenders. Paper presented at the Next Steps in Research on the Assessment and Treatment of Sexually Aggressive Persons (Paraphiliacs), St. Louis, MO.Google Scholar
  37. Zavitzianos, G. (1971). Fetishism and exhibitionism in the female and their relationship to psychopathy and kleptomania. International Journal of Psychoanalysis, 52, 297-305.Google Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Eva W. C. Chow
    • 1
  • Alberto L. Choy
    • 1
  1. 1.Law and Mental Health ProgramCentre for Addiction and Mental HealthTorontoCanada

Personalised recommendations